{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:39:27Z","timestamp":1783489167334,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.arth.2021.01.072","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:07:28Z","timestamp":1612310848000},"page":"2364-2370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates"],"prefix":"10.1016","volume":"36","author":[{"given":"Robert P.","family":"Runner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Shau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Staley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2021.01.072_bib1","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.arth.2019.05.012","article-title":"Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016","volume":"34","author":"Warren","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2106\/00004623-200007000-00004","article-title":"A\u00a0meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty","volume":"82-A","author":"Freedman","year":"2000","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib3","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/ar4616","article-title":"Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study","volume":"16","author":"Migita","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arth.2021.01.072_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.blo.0000161824.52515.31","article-title":"Thromboembolic disease prophylaxis in total hip arthroplasty","volume":"436","author":"Sarmiento","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2021.01.072_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arth.2014.08.006","article-title":"Mechanical thromboembolic prophylaxis with risk stratification in total knee arthroplasty","volume":"30","author":"Hamilton","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.arth.2011.09.024","article-title":"Incidence of clinically significant venous thromboembolic events in Asian patients undergoing total knee arthroplasty without anticoagulation","volume":"27","author":"Bin Abd Razak","year":"2012","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.arth.2011.04.006","article-title":"Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice?","volume":"27","author":"Khatod","year":"2012","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2106\/JBJS.J.01130","article-title":"Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty","volume":"93","author":"Khatod","year":"2011","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11999-013-3358-z","article-title":"Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors","volume":"472","author":"Parvizi","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2021.01.072_bib10","first-page":"41","article-title":"CT pulmonary angiography and pulmonary embolism following 5809 primary joint arthroplasties","volume":"128","author":"Allen","year":"2015","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.arth.2021.01.072_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.arth.2016.10.020","article-title":"The incidence and economic burden of in-hospital venous thromboembolism in the United States","volume":"32","author":"Shahi","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.arth.2013.04.013","article-title":"Clinical outcomes of patients with non-fatal VTE after total knee arthroplasty","volume":"29","author":"Ast","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1302\/0301-620X.91B5.21939","article-title":"The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients","volume":"91","author":"Cusick","year":"2009","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2021.01.072_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.arth.2018.12.015","article-title":"Utilization patterns, efficacy, and complications of venous thromboembolism prophylaxis strategies in primary hip and knee arthroplasty as reported by American Board of Orthopedic Surgery Part II candidates","volume":"34","author":"Runner","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618820167","article-title":"Thromboprophylaxis for hip revision arthroplasty: can we use the recommendations for primary hip surgery? A cohort study","volume":"25","author":"Bautista","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.arth.2021.01.072_bib16","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1177\/0363546512447785","article-title":"Superior labrum anterior and posterior lesions of the shoulder: incidence rates, complications, and outcomes as reported by American Board of Orthopedic Surgery. Part II candidates","volume":"40","author":"Weber","year":"2012","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.arth.2021.01.072_bib17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.2106\/JBJS.15.01049","article-title":"Humeral shaft fracture fixation: incidence rates and complications as reported by American Board of Orthopaedic Surgery Part II candidates","volume":"98","author":"Gottschalk","year":"2016","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.arth.2016.09.006","article-title":"Pulmonary embolism rates following total hip arthroplasty with prophylactic anticoagulation: some pulmonary emboli cannot be avoided","volume":"32","author":"Lieberman","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib19","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2106\/JBJS.L.01328","article-title":"Prevention of venous thromboembolic disease after total hip and knee arthroplasty","volume":"95","author":"Lieberman","year":"2013","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib20","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1302\/0301-620X.94B7.29129","article-title":"The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data","volume":"94","author":"Jameson","year":"2012","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2021.01.072_bib22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1302\/0301-620X.93B11.27622","article-title":"The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry","volume":"93","author":"Jameson","year":"2011","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2021.01.072_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.arth.2015.09.033","article-title":"How much do adverse event rates differ between primary and revision total joint arthroplasty?","volume":"31","author":"Bohl","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2020.02.030","article-title":"Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030","author":"Schwartz","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00264-016-3121-7","article-title":"Revision total hip arthroplasty in the United States: national trends and in-hospital outcomes","volume":"40","author":"Schwartz","year":"2016","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2021.01.072_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2106\/JBJS.17.00470","article-title":"Increasing burden of total hip arthroplasty revisions in patients between 45 and 64 years of age","volume":"100","author":"Rajaee","year":"2018","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"9 Suppl","key":"10.1016\/j.arth.2021.01.072_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.arth.2016.01.065","article-title":"Risk-stratified venous thromboembolism prophylaxis after total joint arthroplasty: aspirin and sequential pneumatic compression devices vs aggressive chemoprophylaxis","volume":"31","author":"Odeh","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.arth.2015.12.007","article-title":"The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty","volume":"31","author":"Nam","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib30","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.arth.2015.06.045","article-title":"Thromboembolism prophylaxis in hip arthroplasty: routine and high risk patients","volume":"30","author":"Nam","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib31","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.arth.2016.12.051","article-title":"Venous thromboembolic disease in revision vs primary total knee arthroplasty","volume":"32","author":"Boylan","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"issue":"9 Suppl","key":"10.1016\/j.arth.2021.01.072_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2106\/JBJS.18.00335","article-title":"Potent anticoagulation does not reduce venous thromboembolism in high-risk patients","volume":"101","author":"Tan","year":"2019","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib34","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.arth.2017.07.028","article-title":"Are revision hip arthroplasty patients at higher risk for venous thromboembolic events than primary hip arthroplasty patients?","volume":"32","author":"Courtney","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2020.03.040","article-title":"Low-dose aspirin is safe and effective for venous thromboembolism prevention in patients undergoing revision total hip arthroplasty: a retrospective cohort study","author":"Tang","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib36","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.arth.2016.03.031","article-title":"Aspirin can be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty","volume":"31","author":"Deirmengian","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"issue":"9 Suppl","key":"10.1016\/j.arth.2021.01.072_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"issue":"9 Suppl","key":"10.1016\/j.arth.2021.01.072_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arth.2015.04.048","article-title":"Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty","volume":"30","author":"Gutowski","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.01.072_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.L.00400","article-title":"Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty","volume":"95","author":"Schousboe","year":"2013","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis","volume":"99","author":"Parvizi","year":"2017","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.01.072_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2017.01.009","article-title":"A\u00a0comparison of two dosing regimens of ASA following total hip and knee arthroplasties","author":"Feldstein","year":"2017","journal-title":"J\u00a0Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540321001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540321001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:35:35Z","timestamp":1760121335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540321001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0883540321001121"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2021.01.072","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2021.01.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}